Loading...
XSTOARJO B
Market cap837mUSD
Dec 23, Last price  
34.64SEK
1D
2.00%
1Q
-21.95%
IPO
42.26%
Name

Arjo AB (publ)

Chart & Performance

D1W1MN
XSTO:ARJO B chart
P/E
19.27
P/S
0.84
EPS
1.80
Div Yield, %
2.51%
Shrs. gr., 5y
—
Rev. gr., 5y
5.97%
Revenues
10.98b
+10.03%
7,568,000,0008,115,000,0007,808,000,0007,688,000,0008,217,000,0008,925,000,0009,078,000,0009,070,000,0009,979,000,00010,980,000,000
Net income
480m
+6.90%
619,000,000307,000,000490,000,000118,000,000296,000,000403,000,000526,000,000742,000,000449,000,000480,000,000
CFO
2.06b
+125.25%
959,000,000811,000,000919,000,000572,000,000991,000,0001,252,000,0002,267,000,0001,734,000,000915,000,0002,061,000,000
Dividend
Apr 19, 20240.9 SEK/sh
Earnings
Jan 28, 2025

Profile

Arjo AB (publ) develops and sells medical devices and solutions for patients with reduced mobility and age-related health challenges in North America, Western Europe, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, treatment and prevention of pressure injuries and leg ulcers, prevention of deep vein thrombosis, treatment of edema, and for obstetric and cardiac diagnostics. The company also provides dementia and bariatric room assessment solutions, as well as clinical consulting, maintenance, and equipment rental and financing solutions. It serves private and public institutions that provide acute and long-term care. The company was founded in 1957 and is headquartered in Malmö, Sweden.
URL
https://www.arjo.com/
IPO date
Dec 12, 2017
Employees
6,800
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
10,980,000
10.03%
9,979,000
10.02%
9,070,000
-0.09%
Cost of revenue
10,041,000
9,181,000
7,936,000
Unusual Expense (Income)
NOPBT
939,000
798,000
1,134,000
NOPBT Margin
8.55%
8.00%
12.50%
Operating Taxes
160,000
149,000
247,000
Tax Rate
17.04%
18.67%
21.78%
NOPAT
779,000
649,000
887,000
Net income
480,000
6.90%
449,000
-39.49%
742,000
41.06%
Dividends
(232,000)
(313,000)
(232,000)
Dividend yield
2.16%
2.95%
0.77%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
2,299,000
2,681,000
4,505,000
Long-term debt
4,348,000
4,800,000
2,106,000
Deferred revenue
559,000
98,000
103,000
Other long-term liabilities
659,000
(2,000)
(2,000)
Net debt
5,165,000
6,011,000
5,325,000
Cash flow
Cash from operating activities
2,061,000
915,000
1,734,000
CAPEX
(403,000)
(900,000)
(760,000)
Cash from investing activities
(638,000)
(902,000)
(695,000)
Cash from financing activities
(1,427,000)
136,000
(1,277,000)
FCF
1,559,000
(409,000)
(1,566,000)
Balance
Cash
923,000
949,000
757,000
Long term investments
559,000
521,000
529,000
Excess cash
933,000
971,050
832,500
Stockholders' equity
7,582,000
7,624,000
6,884,000
Invested Capital
12,794,000
12,955,950
11,545,500
ROIC
6.05%
5.30%
9.08%
ROCE
6.75%
5.65%
9.03%
EV
Common stock shares outstanding
272,370
272,370
272,370
Price
39.40
1.18%
38.94
-64.86%
110.80
76.29%
Market cap
10,731,361
1.18%
10,606,071
-64.86%
30,178,549
76.29%
EV
15,896,361
16,617,071
35,503,549
EBITDA
1,999,000
1,875,000
2,090,000
EV/EBITDA
7.95
8.86
16.99
Interest
267,000
115,000
87,000
Interest/NOPBT
28.43%
14.41%
7.67%